PHASE-II TRIAL OF COMBINATION CHEMOTHERAPY FOR PANCREATIC-CANCER WITH 5-FLUOROURACIL, MITOMYCIN-C, AND HEXAMETHYLMELAMINE

被引：14

作者：

BRUCKNER, HW

STORCH, JA

BROWN, JC

GOLDBERG, J

CHAMBERLIN, K

机构：

[1] CUNY MT SINAI SCH MED,DEPT NEOPLAST DIS,NEW YORK,NY 10029

[2] CUNY MT SINAI SCH MED,DEPT MED MED ONCOL,NEW YORK,NY 10029

来源：

关键词：

D O I：

10.1159/000225717

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：165 / 169

页数：5

共 11 条

[1] [Anonymous], 1979, Ann Surg, V189, P205
[2] BRUCKNER HW, 1982, ONCOLOGY
[3] BUROKER T, 1978, P AM ASSOC CANC RES, V19, P310
[4] EVALUATION OF CYTOTOXIC AGENTS IN HUMAN COLONIC TUMOR XENOGRAFTS AND MOUSE GASTRO-INTESTINAL TISSUES USING A THYMIDINE-H-3 FRACTIONAL INCORPORATION ASSAY
HOUGHTON, JA
HOUGHTON, PJ
[J]. EUROPEAN JOURNAL OF CANCER, 1979, 15 (05) : 763 - 769
[5] COMPARATIVE TOXICITY ON LEUKOCYTES AND PLATELETS OF 2 REGIMENS OF CCNU - RELATIONSHIP BETWEEN MAXIMUM DOSE AND OPTIMUM DOSE
ISRAEL, L
CHAHINIAN, P
[J]. EUROPEAN JOURNAL OF CANCER, 1973, 9 (11-1) : 799 - 802
[6] SCHEIN PS, 1978, CANCER, V42, P19, DOI 10.1002/1097-0142(197807)42:1<19::AID-CNCR2820420103>3.0.CO
[7] 2-4
[8] SMITH FP, 1979, SEMIN ONCOL, V6, P368
[9] STOLINSK.DC, 1972, CANCER, V30, P61, DOI 10.1002/1097-0142(197207)30:1<61::AID-CNCR2820300110>3.0.CO
[10] 2-O